LLY Stock Price, Chart, Stats & News

Eli Lilly and Company (LLY) is a dividend-paying stock with a current dividend yield of 0.56% as of Jul 14, 2026. It pays $6.46 per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 15.23% 5-year compound annual rate.
Dividend safety
Dividend coverage looks healthy — LLY pays out about 22% of earnings.
LLY chart
Fundamentals
Gross margin | 83.79% |
Operating margin | 45.56% |
Pretax margin | 39.48% |
Net margin | 31.66% |
Effective tax rate | 19.79% |
ROA | 18.35% |
ROE | 97.85% |
D/E | 1.60x |
Interest coverage ratio | 37.34x |
LLY valuation
P/E | 39.23x |
P/S | 12.73x |
P/B | 29.72x |
P/CF | 46.91x |
P/FCF | 92.49x |
P/OCF | 46.91x |
PEG | 3.13x |
EV multiple | 28.44x |
About
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500).
Related lists
Similar securities
Based on sector and market capitalization











